Genetic and Immunological Markers of Insulin Dependent Diabetes in Black Americans

References

• Fernandez-Vina M. A., Ramirez L. C., Raskin P., Stastny P. Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans. Tissue Antigens 1993; 41: 57–64
   PubMedGoogle Scholar
• Fletcher J., Mijovic C., Odugbesan O., Jenkins D., Bradwell A. R., Barnett A. H. Transracial studies implicate HLA-DQ as a component of genetic susceptibility to type 1 (insulin-dependent) diabetes. Diabetologia. 1988; 31: 864–870
   PubMed Web of Science ®Google Scholar
• Mijovic C. H., Jenkins D., Jacobs K. H., Penny M. A., Fletcher J. A., Barnett A. H. HLA-DQA1 and-DQB1 alleles associated with genetic susceptibility to IDDM in a Black population. Diabetes 1991; 40: 748–753
   PubMed Web of Science ®Google Scholar
• Neufeld M., Maclaren N., Riley W. J., Lezotte D., McLaughlin J. V., Silverstein J., et al. Islet cell and other organ specific antibodies in U.S.Caucasians and Blacks with insulin-dependent diabetes. Diabetes 1989; 29: 589–592
   Google Scholar
• Békkeskov S., Nielson J. H., Marner B., Bilde T., Ludvigsson J., Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate specific human pancreatic islet cell proteins. Nature 1982; 298: 167–169
   PubMed Web of Science ®Google Scholar
• Christie M., Landin-Olsson M., Sundkvist G., Dahlquist G., Lernmark Å, Békkeskov S. Antibodies to a 64000-Mr islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes. Diabetologia. 1988; 31: 597–602
   PubMed Web of Science ®Google Scholar
• Hagopian W. A., Michelsen B., Karlsen A. E., Larsen F., Moody A., Grubin C. E., et al. Autoantibodies in IDDM primarily recognise the 65000-Mr rather than the 67000-Mr isoform of glutamic acid decarboxylase. Diabetes 1993; 42: 631–636
   PubMed Web of Science ®Google Scholar
• Kritchevsky S. B., Burghen G. A., Hacker D., Kitabchi A. E. The incidence of insulin-dependent diabetes mellitus (IDDM) in Shelby County, Tennessee, in African-Americans (abstract). Am. J. Epidemiol. 1992; 136: 962
   Google Scholar
• American Diabetes Association. Official guide to diagnosis and classification of diabetes mellitus and other categories of glucose intolerance. Diabetes Care 1991; 14: 3–4
   Web of Science ®Google Scholar
• Barmeier H., McCulloch D. K., Neifing J. L., Warnock G., Rajotte R. V., Palmer J. P., et al. Risk for developing IDDM and the presence of islet cell 64K antibodies. Diabetologia. 1991; 34: 727–733
   PubMed Web of Science ®Google Scholar
• Greenbaum C. J., Palmer J. P., Nagataki S., Yamaguchi Y., Molenaar J. L., Van Beers W. A.M., et al. Improved specificity of ICA assays in the Fourth International Immunology of Diabetes Serum Exchange Workshop. Diabetes 1992; 41: 1570–1574
   PubMed Web of Science ®Google Scholar
• Hagopian W. A., Karlsen A. E., Gottsater A., Landin-Olsson M., Grubin C. E., Sundkvist G., et al. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positivity at onset predicts diabetes type. J. Clin. Invest. 1993; 91: 368–374
   PubMed Web of Science ®Google Scholar
• Grubin C. E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W. A., Li L., et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia. 1994; 37: 344–350
   PubMed Web of Science ®Google Scholar
• Petersen J. S., Hejnés K. R., Moody A., Karlsen A. E., Marshall M. O., Hoier-Madsen M., et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a single radioligand assay. Diabetes 1994; 43: 459–467
   PubMed Web of Science ®Google Scholar
• Schimdli R. S., Colman P. G., Bonifacio E., Bottazzo G. F., Harrison L. C. High level of concordance between assays for glutamic acid decarboxylase antibodies. The First Glutaic Acid Decarboxylase Antibody Workshop. Diabetes 1994; 43: 1005–1009
   PubMed Web of Science ®Google Scholar
• Bugawan T. L., Erlich H. A. Rapid typing of HLA-DQB1 DNA polymorphism using nonradioactive oligonucleotide probes and amplified DNA. Immunogenet. 1991; 33: 163–170
   PubMed Web of Science ®Google Scholar
• Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higuchi R., Horn G. T., et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487–491
   PubMed Web of Science ®Google Scholar
• Tiwari J. L., Terasaki P. I. The data and statistical methods. HLA and Disease Associations, J. L. Tiwari, P. I. Terasaki. Springer Verlag, New York 1985; 18–27
   Google Scholar
• Lendrum R. G., Walker G., Gamble D. R. Islet cell antibodies in juvenile diabetes mellitus of recent onset. Lancet 1975; i: 880–883
   Google Scholar
• Bottazzo G. F., Mann J. T., Thorogood M., Baum J. D., Doniach D. Autoimmunity in juvenile diabetics and their families. Br. Med. J. 1978; 2: 165–168
   PubMed Web of Science ®Google Scholar
• Landin-Olsson M., Karlsson A., Dahlquist G., Blom G., Lernmark Å, Sundkvist G. Islet cell and other organ specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes in Sweden during one year and matched control children. Diabetologia. 1989; 32: 387–395
   PubMed Web of Science ®Google Scholar
• Atkinson M. A., Maclaren N. K., Holmes L., Scharp D. W., Lacy P. E., Riley W. J. The natural history and predictive value of Mr 64,000 autoantibodies for insulin-dependent diabetes mellitus. J. Autoimmun. 1990; 3: 41–45
   PubMedGoogle Scholar
• HLA (1992) . Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Volume 2. Oxford, 1991. Oxford University Press
   Google Scholar
• Todd J. A., Mijovic C., Fletcher J., Jenkins D., Bradwell A. L, Barnett A. H. Identification of susceptibility loci for insulin dependent diabetes mellitus by trans-racial gene mapping. Nature 1989; 338: 587–589
   PubMed Web of Science ®Google Scholar
• Cohen D., Cohen O., Marcadet A., Massart G., Lathrop M., Deschamps I., et al. Class II HLA-DC B-chain DNA restriction fragments differentiate among HLA-DR2 individuals with insulin-dependent diabetes and multiple sclerosis. Proc. Natl Acad. Sci. USA 1984; 81: 1774–1779
   PubMed Web of Science ®Google Scholar
• Baisch J. M., Weeks T., Giles T., Hoover M., Stastny P., Capra J. D. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N. Engl. J. Med. 1990; 322: 1836–1841
   PubMed Web of Science ®Google Scholar
• Morel P. A., Dorman J. S., Todd J. A., McDevitt H. O., Trucco M. Aspartic acid at position 57 of the HLA-DQ β chain protects against type I diabetes: A family study. Proc. Natl Acad. Sci. USA 1988; 85: 8111–8115
   PubMed Web of Science ®Google Scholar
• Reijonen H., Ilonen J., Akerblom H. K., Knip M., Dosch H-M. Multi-locus analysis of HLA class II genes in DR2-positive IDDM haplotypes in Finland. Tissue Antigens 1994; 43: 1–6
   PubMedGoogle Scholar
• Zeliszewski D., Tiercy J-M., Boitard C., Gu X-F., Loche M., Krishnamoorthy R., et al. Extensive study of DRB, DQA, and DQB gene polymorphisms in 23 DR2-positive insulin dependent diabetes mellitus patients. Human Immunol. 1992; 33: 140–147
   PubMed Web of Science ®Google Scholar
• Palmer J. P., McCulloch D. K. Prediction and prevention of IDDM—1991. Diabetes 1991; 40: 943–947
   PubMed Web of Science ®Google Scholar
• Bingley P. J., Bonifacio E., Gale E. A.M. Can we really predict IDDM?. Diabetes 1993; 42: 213–220
   PubMed Web of Science ®Google Scholar
• Rowley M. J., Mackay I. R., Chen Q-Y., Knowles W. J., Zimmet P. Z. Antibodies to glutamic acid discriminates major types of diabetes mellitus. Diabetes 1992; 41: 548–551
   PubMed Web of Science ®Google Scholar
• Serjeantson S. W., Kohonen-Corish M. R.J., Rowley M. J., Mackay I. R., Knowles W. J., Zimmet P. Z. Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 96–1001
   PubMed Web of Science ®Google Scholar
• Landin-Olsson M., Palmer J. P., Lernmark Å., Bloom L., Sundkvist G., Nystrom L., et al. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population based study of newly-diagnosed diabetic and matched children. Diabetologia. 1992; 35: 1068–1073
   PubMed Web of Science ®Google Scholar
• Banerji M. A., Chaiken R. L., Huey H., Tuomi T., Norin A. J., Mackay I. R., et al. GAD antibody negative NIDDM in adult Black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Diabetes 1994; 43: 741–745
   PubMed Web of Science ®Google Scholar
• Gianani R., Pugliese A., Bonner-Weir S., Shiffrin A. J., Soeldner J. S., Erlich H., et al. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes. Diabetes 1992; 41: 347–353
   PubMed Web of Science ®Google Scholar
• Horn G. T., Bugawan T. L., Long C M, Erlich H. A. Allelic sequence variation of the HLA-DQ loci: Relationship to serology and to insulin-dependent diabetes susceptibility. Proc. Natl Acad. Sci. USA 1988; 85: 6012–6016
   PubMed Web of Science ®Google Scholar
• Ronningen K. S., Spurkland A., Iwe T., Vartdal F., Thorsby E. Distribution of HLA-DRB1,-DQA1 and-DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 1991; 37: 105–111
   PubMed Web of Science ®Google Scholar
• Bias W. B., Hsu S. H., Pollard M. K., Harvey J., Lotz M., Arnett F. C., et al. HLA-DR characterization of a Chippewa Indian subpopulation with a high prevalence of rheumatoid arthritis. Human Immunol. 1981; 2: 155–163
   PubMed Web of Science ®Google Scholar
• Willkens R. F., Nepom G. T., Marks C. R., Nettles J. W., Nepom B. S. The association of HLA-Dw16 with rheumatoid arthritis in Yakima Indians: Further evidence for the “shared epitope” hypothesis. Arthritis Rheum. 1991; 34: 43–47
   PubMedGoogle Scholar
• Winter W. E., Maclaren N. K., Riley W. J., Clarke D. W., Kappy M. S., Spillar R. P. Maturity-onset diabetes of youth in Black Americans. N. Engl. J. Med. 1987; 316: 285–291
   PubMed Web of Science ®Google Scholar